$CTRE
CareTrust REIT Inc Stock $ctre

$ctre Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023017205 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$51.55M	$50.61M	$46.48M
YoY Change	8.41%	8.89%	1.58%
Cost Of Revenue	$658.0K	$963.0K	$447.0K
YoY Change	639.33%	115.44%
Gross Profit	$50.90M	$49.64M	$46.03M
YoY Change	7.23%	7.85%	0.61%
Gross Profit Margin	98.72%	98.1%	99.04%
Selling, General & Admin	$6.108M	$5.941M	$6.635M
YoY Change	-1.99%	-10.46%	13.61%
% of Gross Profit	12.0%	11.97%	14.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.73M	$12.25M	$13.59M
YoY Change	1.26%	-9.87%	0.8%
% of Gross Profit	25.01%	24.68%	29.53%
Operating Expenses	$18.82M	$18.18M	$20.21M
YoY Change	0.18%	-10.05%	4.66%
Operating Profit	$32.07M	$31.46M	$25.82M
YoY Change	11.85%	21.86%	-2.35%
Interest Expense	$11.04M	$9.827M	$5.742M
YoY Change	75.15%	71.14%	-0.35%
% of Operating Profit	34.42%	31.23%	22.24%
Other Income/Expense, Net
YoY Change
Pretax Income	-$484.0K	$19.23M	-$43.26M
YoY Change	-102.34%	-144.44%	-311.15%
Income Tax
% Of Pretax Income
Net Earnings	-$484.0K	$19.23M	-$43.26M
YoY Change	-102.34%	-144.44%	-311.19%
Net Earnings / Revenue	-0.94%	37.99%	-93.09%
Basic Earnings Per Share	-$0.01	$0.19	-$0.45
Diluted Earnings Per Share	-$0.01	$0.19	-$0.45
COMMON SHARES
Basic Shares Outstanding	99.48M shares	99.51M shares	96.41M shares
Diluted Shares Outstanding	99.12M shares	99.09M shares	96.41M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.145M	$28.07M	$26.59M
YoY Change	-96.22%	5.58%	-12.83%
Cash & Equivalents	$1.145M	$28.07M	$26.59M
Short-Term Investments
Other Short-Term Assets	$14.03M	$29.52M	$5.668M
YoY Change	105.19%	420.78%	-23.41%
Inventory
Prepaid Expenses
Receivables	$387.0K	$441.0K	$1.110M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$15.56M	$58.03M	$33.36M
YoY Change	-59.03%	73.93%	-15.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.695B	$1.542B	$1.418B
YoY Change	12.59%	8.71%	-10.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.34M	$22.59M	$142.5M
YoY Change	-81.5%	-84.15%	7818.5%
Total Long-Term Assets	$1.721B	$1.564B	$1.561B
YoY Change	4.47%	0.23%	-2.12%
TOTAL ASSETS
Total Short-Term Assets	$15.56M	$58.03M	$33.36M
Total Long-Term Assets	$1.721B	$1.564B	$1.561B
Total Assets	$1.737B	$1.622B	$1.594B
YoY Change	3.04%	1.77%	-2.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.04M	$24.17M	$23.79M
YoY Change	-3.26%	1.6%	40.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$48.88M	$52.11M	$50.69M
YoY Change	0.67%	2.81%	18.42%
LONG-TERM LIABILITIES
Long-Term Debt	$875.0M	$729.8M	$698.7M
YoY Change	9.53%	4.45%	4.94%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$875.0M	$729.8M	$698.7M
YoY Change	9.53%	4.45%	4.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.88M	$52.11M	$50.69M
Total Long-Term Liabilities	$875.0M	$729.8M	$698.7M
Total Liabilities	$923.9M	$781.9M	$749.4M
YoY Change	9.02%	4.34%	5.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.247B	$1.246B	$1.197B
YoY Change	4.22%	4.11%	1.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$813.0M	$840.3M	$844.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.737B	$1.622B	$1.594B
YoY Change	3.04%	1.77%	-2.46%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$484.0K	$19.23M	-$43.26M
YoY Change	-102.34%	-144.44%	-311.19%
Depreciation, Depletion And Amortization	$12.73M	$12.25M	$13.59M
YoY Change	1.26%	-9.87%	0.8%
Cash From Operating Activities	$31.87M	$35.12M	$34.58M
YoY Change	-5.51%	1.56%	1.86%
INVESTING ACTIVITIES
Capital Expenditures	$176.8M	$2.019M	-$23.83M
YoY Change	-10440.0%	-108.47%	-82.92%
Acquisitions
YoY Change
Other Investing Activities	$988.0K	$1.201M	-$239.0K
YoY Change	-100.99%	-602.51%	-103.85%
Cash From Investing Activities	-$175.8M	-$818.0K	-$24.07M
YoY Change	73.1%	-96.6%	-81.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	117.0M	-$19.41M	-$3.816M
YoY Change	63.62%	408.65%	-103.44%
NET CHANGE
Cash From Operating Activities	31.87M	$35.12M	$34.58M
Cash From Investing Activities	-175.8M	-$818.0K	-$24.07M
Cash From Financing Activities	117.0M	-$19.41M	-$3.816M
Net Change In Cash	-26.93M	$14.89M	$6.691M
YoY Change	-831.46%	122.57%	-42.07%
FREE CASH FLOW
Cash From Operating Activities	$31.87M	$35.12M	$34.58M
Capital Expenditures	$176.8M	$2.019M	-$23.83M
Free Cash Flow	-$144.9M	$33.10M	$58.41M
YoY Change	-509.08%	-43.33%	-66.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001590717
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36181
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CareTrust REIT, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3999490
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	905 Calle Amanecer
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Clemente
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92673
CY2023Q1	dei	City Area Code CityAreaCode	949
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	542-3130
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	CTRE
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	99475012	shares
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1400813000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1421410000	usd
CY2023Q1	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	140764000	usd
CY2022Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	156368000	usd
CY2023Q1	ctre	Real Estate Investments Accrued Interest RealEstateInvestmentsAccruedInterest	1170000	usd
CY2022Q4	ctre	Real Estate Investments Accrued Interest RealEstateInvestmentsAccruedInterest	1320000	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	17479000	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	12291000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28070000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13178000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	441000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	416000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	29518000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	11690000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5115000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5428000	usd
CY2023Q1	us-gaap	Assets Assets	1622200000	usd
CY2022Q4	us-gaap	Assets Assets	1620781000	usd
CY2023Q1	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	395372000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	395150000	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	199401000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	199348000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	135000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	125000000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	24165000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	24360000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	27943000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	27550000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	781881000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	771408000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99098090	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99098090	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99010112	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99010112	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	991000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	990000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1244793000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1245337000	usd
CY2023Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	405465000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	396954000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	840319000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	849373000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1622200000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1620781000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46163000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46007000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4443000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	469000	usd
CY2023Q1	us-gaap	Revenues Revenues	50606000	usd
CY2022Q1	us-gaap	Revenues Revenues	46476000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12238000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13575000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9827000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	5742000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	880000	usd
CY2022Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1420000	usd
CY2023Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	1886000	usd
CY2022Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	59683000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	usd
CY2023Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	963000	usd
CY2022Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	447000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5061000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5215000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	30855000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	89926000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-70000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	186000	usd
CY2023Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	-454000	usd
CY2022Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	0	usd
CY2023Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-524000	usd
CY2022Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	186000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99063000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96410000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99087000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96410000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	849373000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1479000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	936000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	27738000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	840319000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	915757000	usd
CY2022Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-2772000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1521000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.275
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	26659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	844583000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	usd
CY2023Q1	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	12252000	usd
CY2022Q1	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	13594000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	609000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	520000	usd
CY2023Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	-454000	usd
CY2022Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	0	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1521000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	6000	usd
CY2023Q1	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	0	usd
CY2022Q1	us-gaap	Sales Type Lease Impairment Loss SalesTypeLeaseImpairmentLoss	977000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-150000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-70000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	186000	usd
CY2023Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	1886000	usd
CY2022Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	59683000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	15143000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3844000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-337000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-61000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	404000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-499000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2037000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35120000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34579000	usd
CY2023Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	0	usd
CY2022Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	21915000	usd
CY2023Q1	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	2019000	usd
CY2022Q1	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	1918000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
CY2022Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	2086000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	888000	usd
CY2023Q1	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	17172000	usd
CY2022Q1	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3230000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	959000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-818000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24072000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-501000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10000000	usd
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	25000000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	21000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1479000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2772000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	27409000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26044000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19410000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3816000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14892000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6691000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13178000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19895000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28070000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26586000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6671000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1355000	usd
CY2023Q1	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	393000	usd
CY2022Q1	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	615000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	369000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	0	usd
CY2022Q1	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	7000	usd
CY2023Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	28	state
CY2023Q1	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	140800000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1421410000	usd
CY2023Q1	us-gaap	Land Land	235013000	usd
CY2022Q4	us-gaap	Land Land	238738000	usd
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1477939000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1483133000	usd
CY2023Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	96895000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	97199000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2833000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2832000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1812680000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1821902000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	411867000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	400492000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1400813000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	137942000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	184484000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	184644000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	184750000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	181742000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	179626000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	778259000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1831447000	usd
CY2023Q1	ctre	Period Of Option Window PeriodOfOptionWindow	P6M
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	46170000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	46978000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	6000	usd
CY2023Q1	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	0	usd
CY2022Q1	ctre	Operating Lease Lease Income Adjustments For Collectability OperatingLeaseLeaseIncomeAdjustmentsForCollectability	977000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46163000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46007000	usd
CY2023Q1	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	700000	usd
CY2022Q1	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	600000	usd
CY2022Q1	ctre	Number Of Existing And Former Operators With Doubtful Collectability NumberOfExistingAndFormerOperatorsWithDoubtfulCollectability	4	operator
CY2023Q1	ctre	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	147150000	usd
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	140764000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	156368000	usd
CY2023Q1	ctre	Loan Receivable Origination Fee LoanReceivableOriginationFee	0	usd
CY2022Q1	ctre	Loan Receivable Origination Fee LoanReceivableOriginationFee	2500000	usd
CY2023Q1	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	143000	usd
CY2022Q1	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	888000	usd
CY2023Q1	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	1000	usd
CY2022Q1	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	0	usd
CY2023Q1	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	0	usd
CY2022Q1	ctre	Loan Receivable Provision For Loan Losses Net LoanReceivableProvisionForLoanLossesNet	3844000	usd
CY2023Q1	ctre	Loan Receivable Net Change LoanReceivableNetChange	-144000	usd
CY2022Q1	ctre	Loan Receivable Net Change LoanReceivableNetChange	-2232000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4443000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	469000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	735000000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	5227000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	729773000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	725000000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	5502000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	719498000	usd
CY2020Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-04-14
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	27846000	usd
CY2023Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-03-31
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	573609	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.63
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	159775	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	21.59
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	60545	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	21.20
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	353289	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.10
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1521000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	900000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43264000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	89000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	117000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	19138000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	19138000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43381000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-43381000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99063000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96410000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99087000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96410000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	318000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	534000	shares

Files In Submission

Name	View Source	Status
ctre-20230331_cal.xml	Edgar Link	unprocessable
0001628280-23-017205-index-headers.html	Edgar Link	pending
0001628280-23-017205-index.html	Edgar Link	pending
0001628280-23-017205.txt	Edgar Link	pending
0001628280-23-017205-xbrl.zip	Edgar Link	pending
ctre-20230331.htm	Edgar Link	pending
ctre-20230331.xsd	Edgar Link	pending
ctre20230331ex101amendment.htm	Edgar Link	pending
ctre20230331q1ex311.htm	Edgar Link	pending
ctre20230331q1ex312.htm	Edgar Link	pending
ctre20230331q1ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
ctre-20230331_def.xml	Edgar Link	unprocessable
ctre-20230331_lab.xml	Edgar Link	unprocessable
ctre-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ctre-20230331_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTRE
CareTrust REIT Inc Stock $ctre

2023 Q2 Form 10-Q Financial Statement

#000162828023017205 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE CareTrust REIT Inc Stock $ctre

2023 Q2 Form 10-Q Financial Statement

#000162828023017205 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE
CareTrust REIT Inc Stock $ctre